Epidermal growth factor receptor targeted doxorubicin and vitexin loaded niosomes for enhanced breast cancer therapy

S. Malathi, Valappil Sisila, Vijayapoopathi Singaravel, Nandakumar Venkatesan, Iqbal Pakrudheen, Rajesh Kumar Dhanaraj, Niraikulam Ayyadurai, V. Bhuvarahamurthy, S. Narayana Kalkura

Materials Advances · 2023 · 10 citations · 51 references

DOIFull text

Open access

Abstract

NIODVC (cetuximab-conjugated doxorubicin and vitexin loaded niosome) proves effective for targeted breast cancer therapy. Enhanced cytotoxicity, cellular uptake, and gene downregulation show promise.

References

51